Detalhe da pesquisa
1.
Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients.
J Neuroinflammation
; 17(1): 261, 2020 Sep 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32883348
2.
Human Brain Endothelial CXCR2 is Inflammation-Inducible and Mediates CXCL5- and CXCL8-Triggered Paraendothelial Barrier Breakdown.
Int J Mol Sci
; 20(3)2019 01 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-30704100
3.
Pathogenic inflammation in the CNS of mice carrying human PLP1 mutations.
Hum Mol Genet
; 25(21): 4686-4702, 2016 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28173160
4.
Altered motor plasticity in an acute relapse of multiple sclerosis.
Eur J Neurosci
; 47(3): 251-257, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29285814
5.
Novel insights into neuroinflammation: bacterial lipopolysaccharide, tumor necrosis factor α, and Ureaplasma species differentially modulate atypical chemokine receptor 3 responses in human brain microvascular endothelial cells.
J Neuroinflammation
; 15(1): 156, 2018 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-29792190
6.
Auto-antibodies to contactin-associated protein 1 (Caspr) in two patients with painful inflammatory neuropathy.
Brain
; 139(Pt 10): 2617-2630, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27474220
7.
NFAT1 deficit and NFAT2 deficit attenuate EAE via different mechanisms.
Eur J Immunol
; 45(5): 1377-89, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25630465
8.
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: Afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patients.
J Neuroinflammation
; 13(1): 282, 2016 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27802824
9.
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcome.
J Neuroinflammation
; 13(1): 281, 2016 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27802825
10.
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.
J Neuroinflammation
; 13(1): 280, 2016 09 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-27793206
11.
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.
J Neuroinflammation
; 13(1): 279, 2016 09 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-27788675
12.
Oligoclonal bands predict multiple sclerosis in children with optic neuritis.
Ann Neurol
; 77(6): 1076-82, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25820181
13.
Genome-wide significant association with seven novel multiple sclerosis risk loci.
J Med Genet
; 52(12): 848-55, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26475045
14.
Soluble VCAM-1 impairs human brain endothelial barrier integrity via integrin α-4-transduced outside-in signalling.
Acta Neuropathol
; 129(5): 639-52, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25814153
15.
Fumaric Acid Esters Do Not Reduce Inflammatory NF-κB/p65 Nuclear Translocation, ICAM-1 Expression and T-Cell Adhesiveness of Human Brain Microvascular Endothelial Cells.
Int J Mol Sci
; 16(8): 19086-95, 2015 Aug 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-26287168
16.
Assessment of microRNA-related SNP effects in the 3' untranslated region of the IL22RA2 risk locus in multiple sclerosis.
Neurogenetics
; 15(2): 129-34, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24638856
17.
MANBA, CXCR5, SOX8, RPS6KB1 and ZBTB46 are genetic risk loci for multiple sclerosis.
Brain
; 136(Pt 6): 1778-82, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23739915
18.
OzEAN Study to Collect Real-World Evidence of Persistent Use, Effectiveness, and Safety of Ozanimod Over 5 Years in Patients With Relapsing-Remitting Multiple Sclerosis in Germany.
Front Neurol
; 13: 913616, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35832177
19.
Safety, Adherence and Persistence in a Real-World Cohort of German MS Patients Newly Treated With Ocrelizumab: First Insights From the CONFIDENCE Study.
Front Neurol
; 13: 863105, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35614917
20.
Case reports of PML in patients treated for psoriasis.
N Engl J Med
; 369(11): 1081, 2013 09 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-24024862